Sacramento News-Online

Profacgen Released a CDMO Platform for Drug Discovery and Development Research

 Breaking News
  • No posts were found

Profacgen Released a CDMO Platform for Drug Discovery and Development Research

September 30
23:09 2022
Profacgen is pleased to release a leading CDMO platform that supports one-stop professional services from drug discovery to cGMP production for worldwide biopharmaceutical and biotechnology companies.

New York, USA – September 30, 2022 – Profacgen, a biotechnology company dedicated to offering comprehensive one-stop services for pre-clinical drug development, is pleased to release a leading CDMO platform that supports one-stop professional services from drug discovery to cGMP production for worldwide biopharmaceutical and biotechnology companies.

Pharmaceutical companies are struggling to create and manufacture drug substances as pharmacological substances get more sophisticated. To bring solutions to market faster, innovation and production need to happen more quickly, and many pharmaceutical companies are focused on controlling costs, if not really lowering them.

With the right CDMO chose, pharmaceutical companies can gain flexibility, collaboration and innovation services to contribute to accelerating time to market and reducing costs by offering knowledge and resources outside of their own organization.

Backed by years’ experience, Profacgen delivers the integrated platform for every step of drug development, from early-stage research all the way to commercialization.

Featured services at Profacgen include:

GMP grade stable cell line development

GMP grade stable cell line development system at Profacgen can improve the protein expression and yield of cells, shorten about half the development time of stable cell lines, and provide a variety of special requirements such as label free expression and serum-free suspension culture.

IND-enabling Non-cGMP Production and cGMP Manufacturing

Profacgen provides preclinical, clinical and listed drug production services, including non GMP standard production workshops and modular biomedical factories in line with global cGMP standards.

IND-enabling Process Development Services

Profacgen provides the most efficient and economical process development mode, including cell culture process development, protein purification process development, formulation and process development.

“With the release of the CDMO platform, we can help you meet deadlines or quickly scale up to meet production demand and save cost and time. And the highest standard quality system, a complete quality management system and an experienced quality management team can effectively meet the requirements of global regulations for biological product production facilities.” Commented Crystal, the chief marketing staff at Profacgen.

To know more detailed information about the CDMO services supported by Profacgen, please visit https://www.profacgen.com/pharmaceutical-contract-development-and-manufacturing-organization-cdmo.

Media Contact
Company Name: Profacgen
Contact Person: Ellen
Email: Send Email
Phone: 1-516-855-7709
Country: United States
Website: https://www.profacgen.com